Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001415889-24-015508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-04 | 2024-05-31+ | OLMA | Harmon Cyrus | Dir | S - Sale | $10.30 | -25.0K | 786.3K | -3% | -$257.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | S | D | 5,000 | $12.33 | 781,283 | D | — | — | (F4) The weighted average sale price for the transaction reported was $12.33, and the range of prices was between $12.23 and $12.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2024-05-31 | S | D | 15,000 | $9.41 | 791,283 | D | — | — | (F2) The weighted average sale price for the transaction reported was $9.41, and the range of prices was between $9.34 and $9.56. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2024-06-03 | S | D | 5,000 | $10.93 | 786,283 | D | — | — | (F3) The weighted average sale price for the transaction reported was $10.93, and the range of prices was between $10.91 and $11.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |